SCHEMBL2365704

SCHEMBL2365704

COC(=O)c1c(C)cc(=O)[nH]c1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.50
ACHE P22303 1/20 0.50
NR4A2 P43354 2/20 0.47
HPGD P15428 1/20 0.47
CYP1A2 P05177 1/20 0.46
TSHR P16473 3/20 0.40
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
POLB P06746 2/20 0.40
GLO1 Q04760 1/20 0.39
NGFR P08138 1/20 0.38
ALDH1A1 P00352 2/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
KDM4E B2RXH2 1/20 0.38
GLA P06280 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10073230 0.74 CYP3A4 (0.55) CYP3A4ACHEHPGDTSHRMAPT
SCHEMBL20503232 0.71 CYP3A4 (0.68) CYP3A4ACHENR4A2HPGDTSHR
SCHEMBL197898 0.71 CYP3A4 (0.81) CYP3A4ACHEHPGDMAPTLMNA
SCHEMBL27980095 0.70 CYP3A4 (0.51) CYP3A4ACHENR4A2HPGDCYP1A2
SCHEMBL29576982 0.69 CYP3A4 (0.50) CYP3A4ACHENR4A2HPGDTSHR
SCHEMBL28903095 0.69 CYP3A4 (0.50) CYP3A4ACHENR4A2HPGDTSHR
SCHEMBL22754120 0.69 CYP3A4 (0.50) CYP3A4ACHEHPGDTSHRMAPT
SCHEMBL2021435 0.69 CYP3A4 (0.50) CYP3A4ACHEHPGDTSHRMAPT
SCHEMBL26662775 0.69 ALDH1A1 (0.49) CYP3A4ACHENR4A2HPGDCYP1A2
SCHEMBL6024268 0.69 NR1H2 (0.60) CYP3A4HPGDCYP1A2MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2364973-B1 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF ARRAY BIOPHARMA INC (US) 2014-07-09 EP disclosed
EP-1922307-B1 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF ARRAY BIOPHARMA INC (US) 2011-12-28 EP disclosed
EP-2364973-A1 Heterocyclic inhibitors of MEK and Methods of use thereof Array Biopharma, Inc. (US) 2011-09-14 EP disclosed
EP-1922307-A2 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF Array Biopharma, Inc. (US) 2008-05-21 EP disclosed
WO-2007044084-A2 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF ARRAY BIOPHARMA INC. (US) 2007-04-19 WO disclosed